相关实验视频

Updated: Jun 23, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

布:在瘤学中简化多学科瘤委员会建议的背景感知数据驱动人工智能

Dania Daye^1,2,3, Regina Parker², Satvik Tripathi^1,2,3

¹Massachusetts General Hospital, Boston, MA 02114, USA.

|June 19, 2024

概括

机器学习准确地预测肝细胞癌 (HCC) 治疗建议,优于既定指导方针. 这种人工智能工具可以帮助临床决策,特别是在专家子专业护理有限的地方.

科学领域:

在瘤学瘤学.
医疗信息学医疗信息学
人工智能的人工智能

背景情况:

肝细胞癌 (HCC) 治疗决策是复杂的,通常需要多学科瘤委员会 (MTB) 的投入.
现有的治疗指南可能无法捕捉个体患者病例的细微差别,以实现最佳的HCC管理.
集成先进的计算方法,如机器学习 (ML),为改善治疗预测提供了潜力.

研究的目的:

评估机器学习算法在预测HCC患者治疗建议方面的有效性.
将ML模型的预测准确性与既定临床指南 (ESMO,NCCN) 进行比较.

主要方法:

在IRB批准的多学科瘤委员会讨论的140名HCC患者的回顾性分析.
提取临床和成像变量作为输入到渐变增强机器学习算法 (XGBoost) 中.
使用混矩阵指标和接收器操作特征 (ROC) 曲线分析进行性能评估.

主要成果:

XGBoost ML模型显示了对MTB提出的所有八种治疗建议的预测能力.
与ESMO和NCCN指南推相比,ML模型的预测显示出更高的准确性.
该模型成功地整合了各种临床和成像数据,用于预测建模.

结论:

使用临床和成像数据的机器学习模型可以可靠地预测专家推的HCC治疗方法.
这种由人工智能驱动的方法在支持临床决策方面表现有前途,特别是在资源有限的环境中.
机器学习模型为个性化HCC治疗计划的传统指南提供了有价值的补充.

关键词:

计算机算法算法计算机算法肝细胞癌是肝细胞癌.机器学习是机器学习.多学科的决策能力.瘤委员会瘤委员会

更多相关视频

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...